23andMe 23andMe Stock Soars 22 Percent on Closing of Merger With VG Acquisition Corp The company's official acquisition by the Virgin Group's special purpose acquisition company signaled its first day as a publicly traded entity on the Nasdaq. In Brief This Week: Bio-Rad, 10x Genomics, IsoPlexis, 23andMe, PerkinElmer, LifeBit Biotech, More News items for the week of May 24, 2021. 23andMe Begins Reporting PGx Variants With Drug Info Under Recent FDA Clearance Premium The new reports link variants in CYP2C19 to the safety and efficacy of two drugs, a commonly prescribed antiplatelet drug and an antidepressant. 23andMe Team Sees Genetic, Nongenetic Contributors to COVID-19 Risk in Trans-Ancestry Study The researchers linked two genetic loci to disease susceptibility or severity, although socioeconomic levels and ancestry influenced hospitalizations, as well. Genomics Firms Taking Advantage of SPACs Trend to Go Public Faster Premium As the life science industry left 2020 behind, it joined a new trend: going public through a mechanism that combines an IPO and merger in one transaction. Feb 4, 2021 23andMe to Go Public Through Merger With Virgin Group Acquisition Firm Jan 21, 2021 Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics Premium Dec 29, 2020 23andMe Raises $82.5M in Private Financing Nov 12, 2020 OncoCyte Posts $555K in Q3 Revenues, Net Loss Rises Aug 28, 2020 Stakeholders Scramble to Predict Impact of HHS Move Limiting FDA Ability to Regulate LDTs Premium Aug 18, 2020 23andMe Garners FDA Clearance for CYP2C19 PGx Test Report Aug 3, 2020 Ancestry Rolls Out Sequencing-Based Health Offering Focused on Common Conditions Premium Jul 23, 2020 Genetic Study Validates, Expands History of Transatlantic Slave Trade Premium Jun 15, 2020 U of Edinburgh Study to Use Consumer Genomics Data to Determine COVID-19 Genetic Risk Apr 24, 2020 Ancestry to Make Consumer Genomics Database Available for COVID-19 Research Project Apr 23, 2020 Finland's Negen Introduces Pharmacogenomics Panel for COVID-19 Therapies Apr 8, 2020 23andMe to Study Genetic Factors of COVID-19 Severity Using Data From Consented Customers Mar 30, 2020 Refractive Error GWAS Leads To More Than 300 New Loci Mar 6, 2020 As Consumer Genomics Market Cools, Providers Ponder Better Ways to Reach Customers Premium Feb 6, 2020 Ancestry Lays off 6 Percent of Employees due to Consumer Slump Jan 31, 2020 Translational Software to Submit PGx Software Platform for 510(k) Clearance Premium Jan 23, 2020 23andMe Lays off 100 Employees Across Consumer Business Jan 9, 2020 Forensic Genomics Market Advances Due to Consumer Databases, Technology Innovation Premium Dec 10, 2019 Celmatix Sues 23andMe for $100M Alleging Breach of Contract Oct 10, 2019 Uniparental Disomy More Common in General Population Than Previously Thought Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.